Actualités Forex
European Stocks Close Higher On Bargain Hunting, Some Positive Economic Data
European stocks closed on a strong note on Wednesday, rebounding after suffering sharp losses in the previous session amid rising concerns about a possible recession.
RTTNews |
il y a 695
U.S. Dollar Advances Amid Strong ISM Services PMI; Fed Minutes Due
The U.S. dollar was higher against its major counterparts in the European session on Wednesday, as the nation's service sector activity improved in June and investors awaited the release of the minutes of the Federal Reserve's June policy meeting for clues about the future path of monetary tightening.
RTTNews
|
il y a 695
Wall Street Likely To Open With Negative Bias
Lower U.S. index futures point to a slightly negative start on Wall Street on Wednesday.
RTTNews
|
il y a 695
Inspire Medical Says FDA Oks Addl. MRI Scan Conditions For Use With Inspire Therapy
Medical technology company Inspire Medical Systems, Inc. (INSP) announced Wednesday that the U.S. Food and Drug Administration (FDA) has approved additional magnetic resonance imaging (MRI) scan conditions for use with Inspire therapy.
RTTNews
|
il y a 695
Catalyst Biosciences Says Court Denies Motion For Expedited Proceedings By JDS1
Catalyst Biosciences, Inc. (CBIO) announced Wednesday that the Delaware Court of Chancery has denied the motion for expedited proceedings in the action brought by the plaintiff, JDS1, LLC.
RTTNews
|
il y a 695
Bay Street Likely To See Positive Start
Higher crude oil prices and firm European markets indicate a positive start for the Canadian market on Wednesday.
RTTNews
|
il y a 695
Coherus, Junshi Biosciences Say FDA Accepts Resubmission Of Toripalimab BLA
Coherus BioSciences, Inc. (CHRS) and Shanghai Junshi Biosciences Co., Ltd. announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) resubmission for toripalimab in combination with gemcitabine and cisplatin as first-line treatment for patients with advanced recurrent or metastatic nasopharyngeal carcinoma (NPC) and for toripalimab monotherapy for the second-line or later treatment of recurrent or metastatic NPC after platinum-containing chemotherapy.
RTTNews
|
il y a 695
more news
AllianceBernstein Appoints COO Kate Burke To Addl. Role Of CFO
Investment management firm AllianceBernstein Holding L.P. (AB) and AllianceBernstein L.P. announced Wednesday it has appointed Kate Burke as Chief Financial Officer, effective immediately. She assumes this role while maintaining her role as Chief Operating Officer.
RTTNews
|
il y a 695
Air Products, VPI Ink Joint Development Deal For "Humber Hydrogen Hub"
Industrial gases company Air Products (APD) announced Wednesday the signing of a joint development agreement to drive forward the "Humber Hydrogen Hub" or "H3", which seeks to develop a flagship 800MW low-carbon hydrogen production facility in Immingham, UK.
RTTNews
|
il y a 695
CMA Probes Amazon Over Suspected Anti-competitive Practices
The Competition and Markets Authority (CMA) said Wednesday it is investigating Amazon.com (AMZN) over concerns that practices affecting sellers on its UK Marketplace may be anti-competitive and could result in a worse deal for customers.
RTTNews
|
il y a 695
Malaysia Central Bank Hikes Rate Again By 25 Bps
Malaysia's central bank raised its key interest rate by a quarter-point for the second straight meeting on Wednesday and signaled a gradual tightening going forward.
The Monetary Policy Committee of Bank Negara Malaysia decided to increase the benchmark Overnight Policy Rate by 25 basis points to 2.25 percent.
RTTNews
|
il y a 695
Comscore Promoted CFO Jon Carpenter To Succeed Bill Livek As CEO
Comscore, Inc. (SCOR) announced Wednesday that Jon Carpenter, who has served as the company's chief financial officer since November 2021, has been appointed by Comscore's board of directors as chief executive officer, effective today.
RTTNews
|
il y a 695
JinkoSolar Board Approves Repurchase Of Up To $200 Mln ADSs
Chinese solar module manufacturer JinkoSolar Holding Co., Ltd. (JKS) announced Wednesday that its board of directors has approved a share repurchase program, which authorizes the Company to repurchase up to $200 million of its ordinary shares represented by American depositary shares (ADSs) during an 18-month period.
RTTNews
|
il y a 695
Stay up to date!
Add Actualités to your browser
